Skip to main content

Latest SEC Filings — Page 186

Page 186 · 30 filings scored 7+ · newest 9:00 AM ET · How scores work

Thu, Aug 1330 filings
7RENXRenX Enterprises Corp.RenX Posts Record Q2 Revenue of $4.26M, Logistics Turns Profitable AgainForm 8-K · Current report▲ Positive7LWAYLifeway Foods, Inc.Record Q2 Sales of $66.9M for Lifeway Foods, but Margin Compression Erodes ProfitForm 8-K · Current report● Neutral7AETNAETERNUM HEALTH, INC.Aeternum Pays 50M Shares for Option on 51% of Nkamouna Cobalt-Nickel ProjectForm 8-K · Current report● Neutral8GLNGGolar LNG LtdGolar LNG Q2 2026: Net Income Up 145%, Fourth FLNG Ordered, $600M RCF ClosedForm 6-K · Current report▲ PositivePro7DWTXDogwood Therapeutics, Inc.Dogwood Q2 Loss Widens on $6.7M Impairment; Halneuron Phase 2b Topline Data on Track for FallForm 8-K · Current report● Neutral8CINGCingulate Inc.Cingulate Q2 10-Q: $28.4M Cash, Going Concern Doubt, FDA CRL DetailsForm 10-Q · Periodic report▼ NegativePro7ASICAtegrity Specialty Insurance Co HoldingsAtegrity Q2 2026 10-Q: Record Earnings, $2.8M Buyback, and $10M Fund InvestmentForm 10-Q · Periodic report▲ Positive8EQPTEquipmentShare.com IncEquipmentShare Q2 2026: Revenue Up 26%, $1.35B Notes Issued, $500M Buyback AuthorizedForm 10-Q · Periodic report● NeutralPro7PHIPLDT Inc.PLDT Declares P46/Share Interim Dividend and Promotes Three OfficersForm 6-K · Current report● Neutral8ONCH1RT Acquisition Corp.1RT Acquisition Corp. Reaffirms Going Concern Warning as Cash Dwindles to $36KForm 10-Q · Periodic report▼ NegativePro7CINGCingulate Inc.Cingulate Reports Q2 2026 Results: $28.4M Cash Runway Through Mid-2027, NDA Resubmission in ProgressForm 8-K · Current report● Neutral8PDSBPDS Biotechnology CorpPDS Biotech Reports Q2 Loss, Cash Drops to $5.6M, and PDS0301 Shows Strong Colorectal Cancer DataForm 8-K · Current report▼ NegativePro8SGRPSPAR Group, Inc.SPAR Group 10-Q Reveals Material Weakness, Shareholder Derivative Lawsuit, and ArbitrationForm 10-Q · Periodic report▼ NegativePro7OVIDOvid Therapeutics Inc.Ovid Q2 2026: $15M Net Loss, $169.8M Cash, and New Financing DetailsForm 10-Q · Periodic report● Neutral8HTCRHeartCore Enterprises, Inc.HeartCore Q2 10-Q: $2.0M Net Loss, Going Concern Warning, Cash Down to $587KForm 10-Q · Periodic report▼ NegativePro7OVIDOvid Therapeutics Inc.Ovid's Q2 2026: Cash Runway to 2029, OV329 Phase 2 Underway, and a Soticlestat Deal Worth Up to $294.5MForm 8-K · Current report▲ Positive7FATEFATE THERAPEUTICS INCFate Therapeutics Reports Q2 2026 Results: First Patient Dosed in Pivotal Lupus Nephritis Trial, Cash Runway into 2028Form 8-K · Current report▲ Positive8NAKANakamoto Inc.Nakamoto Posts $133M Q2 Loss on $105M Goodwill Impairment and Bitcoin DeclineForm 10-Q · Periodic report▼ NegativePro8CABRCaring Brands, Inc.Caring Brands 10-Q Reveals Material Weaknesses, Going Concern, and Nasdaq Delisting RiskForm 10-Q · Periodic report▼ NegativePro8KTWOK2 Capital Acquisition CorpK2 Capital Flags Going Concern Doubt as SPAC Deadline LoomsForm 10-Q · Periodic report▼ NegativePro7DUKRDUKE Robotics Corp.Q2 Loss Widens to $726K, but $9.2M Offering Extends Cash RunwayForm 10-Q · Periodic report● Neutral7CADLCandel Therapeutics, Inc.Candel Q2 Loss Widens to $38.9M; Cash Runway Extended to Q1 2028Form 10-Q · Periodic report● Neutral7HTCRHeartCore Enterprises, Inc.HeartCore Q2 Revenue Up 72% but Net Loss Widens to $2M; Cash Drops to $587KForm 8-K · Current report▼ Negative7PARABanzai International, Inc.Banzai Closes $1.1M Convertible Note at $1.96, Deep Discount to Prior $2.75Form 8-K · Current report▼ Negative8ONDSOndas Inc.Ondas Posts Record Q2 Revenue of $83.8M, Raises Full-Year Outlook to $525–$550MForm 8-K · Current report▲ PositivePro8DFSCDEFSEC Technologies Inc.DEFSEC Q3 Revenue Up 92%, BLISS™ Passes U.S. Army TestingForm 6-K · Current report▲ PositivePro8SNDASonida Senior Living, Inc.Sonida Secures $380M Term Loan to Refinance Debt and Extend MaturityForm 8-K · Current report● NeutralPro7LUCDLucid Diagnostics Inc.Lucid Diagnostics Q2 2026: Revenue Climbs 27% and First LBM Coverage Policy SecuredForm 8-K · Current report● Neutral8MGTXMeiraGTx Holdings plcMeiraGTx Q2 2026: $160.7M Profit, Cash Runway to H2 2028, Oberland Capital Deal DetailsForm 10-Q · Periodic report▲ PositivePro7EYENational Vision Holdings, Inc.National Vision Q2 10-Q: $31.6M Adjusted Operating Income, $20M Buyback, $3.1M RestructuringForm 10-Q · Periodic report▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.